Poxel Announces Election of Pierre Legault as Chairman of the Board of Directors

Published: 19 April 2016

POXEL SA (Euronext - POXEL - FR0012432516), a clinical-stage biopharmaceutical company focused on the development of novel treatments for type 2 diabetes and metabolic disease, today announced that...

The role of Cbl-mediated ubiquitination in the regulation of the Met RTK

Monday, May 9, 2005 12:00

3655 promenade Sir William Osler, Montreal, QC, H3G 1Y6, CA/channelsCategory: Dept. of Biochemistry Biochemistry Senior Seminar Medicine and Health Sciences

Using enzyme structure to design new enantioselective biocatalytic reactions

Monday, September 18, 2006 16:00

801 rue Sherbrooke Ouest, Montreal, QC, H3A 0B8, CA/channelsCategory: Dept. of Chemistry Chemical Society Seminar Faculty of Science

Prognosis in disorders of consciousness: Ethics

Friday, April 25, 2008 08:30

3801 rue University, Montreal, QC, H3A 2B4, CA/channelsCategory: McGill University Health Centre (MUHC) Research news McGill Neurology Conference Medicine and Health Sciences MNI

Pages

Back to top